Obezitenin Tanımı ve Epidemiyoloji
Synopsis
Obezite yağ dokusunun aşırı artışı ile karakterize multifaktöriyel bir hastalık olup, bulaşıcı olmayan birçok hastalık için artmış bir risk faktörüdür. Aşırı kilo ve obezite erişkin popülasyonun yüzde 60’ını ve yaklaşık üç çocuktan birini etkilemektedir. Covid-19 pandemisi sırasında yapılan çalışmalarda obezite prevalansının tüm dünyada arttığı ve mortalite ve morbidite artışı ile ilişkisi net bir şekilde görülmüştür. Obezite, Dünya Sağlık Örgütü’nün sigara, yüksek kan basıncı ve kan şekeri kontrolünden sonra dördüncü sırada önleme çalışmaları yaptığı küresel bir risk faktörüdür. Obezite prevalansının dünyanın her bölgesinde artması ve hiçbir bölgesinde % 2’nin altında olmaması obezite ile mücadelede bütün ülkelerin işbirliği yapması gerektiğini göstermektedir.
References
World Health Organization. Who fact sheet on overweight. Updated October 2017. http://www.who.int/mediacentre/factssheets/fs311/en/. Erişim tarihi: 08 Aralık 2017.
Global health estimates: life expectancy and leading causes of death and disability. In: Global Health Observatory. Geneva: World Health Organization; 2021 (https://www.who.int/data/themes/mortality-and-global-health-estimates).
Global Action Plan fort he Prevention and Control of Noncommunicable Diseases 2013-2020. Geneva: World Health Organization; 2013 (https://apps.who.int/iris/handle/10665/94384).
Obesity prevention: Clinical guidelines (CG43). London: National İnstitute for Health and Care Excellence; 2006 (https://www.nice.org.uk/guidance/cg43).
NCD Risk Factor Collaboration (NCD-RisC). Worldwide Trends in Body-Mass Index, Underweight, Overweight, and Obesity From 1975 to 2016: A Pooled Analysis of 2416 Population-Based Measurement Studies in 128·9 Million Children, Adolescents, and Adults. Lancet (2017) 390(10113):2627–42. doi: 10.1016/S0140-6736(17)32129-3.
Obesity: preventing and managing the global epidemic. Report of a WHO consültation. Geneva: World Health Organization; 2000 (https://apps.who.int/iris/handle/10665/42330).
Bray GA, Kim KK, Wilding JWorld Obesity Federation. Obesity: A Chronic Relapsing Progressive Disease Process. A Position Statement of the World Obesity Federation. Obes Rev (2017) 18(7):715–23.doi: 10.1111/obr.12551.
Telles S, Gangadhar BN, Chandwani KD. Lifestyle Modification in the Prevention and Management of Obesity. J Obes (2016) 2016:5818601. doi: 10.1155/2016/5818601
Guidelines (2013) for Managing Overweight and Obesity in Adults. Preface to the Expert Panel Report (Comprehensive Version Which Includes Systematic Evidence Review, Evidence Statements, and Recommendations). Obes (Silver Spring) (2014) 22 Suppl 2:S40. doi: 10.1002/oby.20822
Gomez G, Stanford FC. US Health Policy and Prescription Drug Coverage of FDA-Approved Medications for the Treatment of Obesity. Int J Obes (Lond) (2018) 42(3):495–500. doi: 10.1038/ijo.2017.287.
Angelidi AM, Belanger MJ, Kokkinos A, Koliaki CC, Mantzoros CS. Novel non-invasive approaches to the treatment of obesity: from pharmacotherapy to gene therapy. Endocr Rev 2021. https://doi.org/10.1210/ENDREV/BNAB034.
Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol 2019;15:288–98. https://doi.org/10.1038/S41574-019-0176-8.
Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013;28(2):169-80.
Satman İ. Türkiye’de obezite sorunu. Turkiye Klinikleri J Gastroenterohepatol-Special Topics 2016;9(2):1-11.
Global health estimates: life expectancy and leading causes of death and disability. In: Global Health Observatory. Geneva: World Health Organization; 2021 (https://www.who.int/data/themes/mortality-and-global-health-estimates).
Global Action Plan fort he Prevention and Control of Noncommunicable Diseases 2013-2020. Geneva: World Health Organization; 2013 (https://apps.who.int/iris/handle/10665/94384).
Obesity prevention: Clinical guidelines (CG43). London: National İnstitute for Health and Care Excellence; 2006 (https://www.nice.org.uk/guidance/cg43).
NCD Risk Factor Collaboration (NCD-RisC). Worldwide Trends in Body-Mass Index, Underweight, Overweight, and Obesity From 1975 to 2016: A Pooled Analysis of 2416 Population-Based Measurement Studies in 128·9 Million Children, Adolescents, and Adults. Lancet (2017) 390(10113):2627–42. doi: 10.1016/S0140-6736(17)32129-3.
Obesity: preventing and managing the global epidemic. Report of a WHO consültation. Geneva: World Health Organization; 2000 (https://apps.who.int/iris/handle/10665/42330).
Bray GA, Kim KK, Wilding JWorld Obesity Federation. Obesity: A Chronic Relapsing Progressive Disease Process. A Position Statement of the World Obesity Federation. Obes Rev (2017) 18(7):715–23.doi: 10.1111/obr.12551.
Telles S, Gangadhar BN, Chandwani KD. Lifestyle Modification in the Prevention and Management of Obesity. J Obes (2016) 2016:5818601. doi: 10.1155/2016/5818601
Guidelines (2013) for Managing Overweight and Obesity in Adults. Preface to the Expert Panel Report (Comprehensive Version Which Includes Systematic Evidence Review, Evidence Statements, and Recommendations). Obes (Silver Spring) (2014) 22 Suppl 2:S40. doi: 10.1002/oby.20822
Gomez G, Stanford FC. US Health Policy and Prescription Drug Coverage of FDA-Approved Medications for the Treatment of Obesity. Int J Obes (Lond) (2018) 42(3):495–500. doi: 10.1038/ijo.2017.287.
Angelidi AM, Belanger MJ, Kokkinos A, Koliaki CC, Mantzoros CS. Novel non-invasive approaches to the treatment of obesity: from pharmacotherapy to gene therapy. Endocr Rev 2021. https://doi.org/10.1210/ENDREV/BNAB034.
Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol 2019;15:288–98. https://doi.org/10.1038/S41574-019-0176-8.
Satman I, Omer B, Tutuncu Y, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013;28(2):169-80.
Satman İ. Türkiye’de obezite sorunu. Turkiye Klinikleri J Gastroenterohepatol-Special Topics 2016;9(2):1-11.
Pages
1-6
Published
February 3, 2023
Copyright (c) 2023 Academician Book Portal
License
LicenseHow to Cite
1.
Köseoğlu R. Obezitenin Tanımı ve Epidemiyoloji. In: Peker G, editor. Obezite ve Ortopedik Hastalıklar [Internet]. Türkiye: Academician Publishing Book DOI Portal; 2023 [cited 2026 Jul. 16]. pp. 1-6. Available from: https://omp35.books.akademisyen.net/index.php/akya/catalog/book/2465/chapter/13821
